Androstenedione: 4-Androstenedione (androst-4-ene-3,17-dione) – an endogenous weak androgen and estrogen and intermediate to/prohormone of testosterone.
Scope of the Report:
Androstenedione is used to evaluate the function of the adrenal gland and the ovaries or the testicles as well as the production of hormones related to the development of male sex organs and physical characteristics (androgens). It is most commonly used to determine the cause of symptoms of excess androgens in a woman who has an elevated testosterone level, along with a few other laboratory tests for this purpose.
Androstadienedione (1,4-androstadiene-3,17-dione) is an important industrial precursor for various steroid hormones. Androstadienedione is an important industrial-scale precursor for a wide variety of steroid hormones within the estrane and androstane classifications.
The worldwide market for Androstenedione is expected to grow at a CAGR of roughly 0.8% over the next five years, will reach 200 million US$ in 2024, from 190 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Androstenedione in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
BIOVET
Indo Phyto Chemicals
Sito Bio
Goto Pharmaceutical
Tianjin King York
Jiufu
Yongning Pharma
Jiangxi Hongyuan Pharmaceutical
Kaizon
Xi’an Gaoyuan Bio-Chem
Dongyao Pharmaceutical
Huazhong Pharmaceutical
Darui
Danjiangkou Danao
Dahua Pharmaceutical
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
4-AD
ADD
Market Segment by Applications, can be divided into
Arthritis Pharmaceuticals
Fertility Control Pharmaceuticals
Infectious Inflammation Pharmaceuticals
Others
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Androstenedione product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Androstenedione, with price, sales, revenue and global market share of Androstenedione in 2017 and 2018.
Chapter 3, the Androstenedione competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Androstenedione breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Androstenedione market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Androstenedione sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Summary:
Get latest Market Research Reports on Androstenedione . Industry analysis & Market Report on Androstenedione is a syndicated market report, published as Global Androstenedione Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Androstenedione market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.